These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 2449226)
1. Mechanically induced ventricular extrasystoles in the isolated perfused guinea-pig heart. A model to study cardiac arrhythmia and to differentiate antiarrhythmic drugs. Nolte S; Döring HJ; Frey A Arzneimittelforschung; 1987 Sep; 37(9):1025-9. PubMed ID: 2449226 [TBL] [Abstract][Full Text] [Related]
2. Cardiac effects of quinidine on guinea-pig isolated perfused hearts after in vivo quinidine pretreatment. Yang Q; Padrini R; Piovan D; Ferrari M Br J Pharmacol; 1997 Sep; 122(1):7-12. PubMed ID: 9298522 [TBL] [Abstract][Full Text] [Related]
3. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304 [TBL] [Abstract][Full Text] [Related]
4. [Can atrial fibrillation be managed without anti-arrhythmia drugs?]. Blanc JJ; Mansourati J Arch Mal Coeur Vaiss; 1994 Sep; 87 Spec No 3():63-7. PubMed ID: 7786126 [TBL] [Abstract][Full Text] [Related]
5. Effects of antiarrhythmic drugs in the isolated papillary muscle preparation of the guinea-pig. Bandolet J; Rump S Pol J Pharmacol Pharm; 1989; 41(6):519-25. PubMed ID: 2485901 [TBL] [Abstract][Full Text] [Related]
6. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study. Vaillant F; Timour Q; Descotes J; Manati W; Belhani D; Bui-Xuan B; Tabib A; Bricca G; Chevalier P J Cardiovasc Pharmacol; 2008 Dec; 52(6):548-54. PubMed ID: 19034029 [TBL] [Abstract][Full Text] [Related]
7. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model. Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223 [TBL] [Abstract][Full Text] [Related]
8. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation. Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759 [TBL] [Abstract][Full Text] [Related]
9. Effects of flecainide on atrial and ventricular stimulation thresholds to repetitive extrasystoles and fibrillation and on "2nd Phase" ventricular arrhythmias in dogs. Heuer H; Gülker H; Thale J; Bender F Arzneimittelforschung; 1983; 33(12):1651-4. PubMed ID: 6199033 [TBL] [Abstract][Full Text] [Related]
10. Effects of class I antiarrhythmic drugs on the digitalis-induced triggered activity arrhythmia model: a rationale for the short-term use of class I drugs against triggered arrhythmias. Takahara A; Sugiyama A; Hashimoto K Heart Vessels; 2004 Jan; 19(1):43-8. PubMed ID: 14685755 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacological restoration and maintenance of sinus rhythm by antiarrhythmic agents]. Sugi K J Cardiol; 1999 Mar; 33 Suppl 1():59-64. PubMed ID: 10342138 [TBL] [Abstract][Full Text] [Related]
13. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart. Hearse DJ; Ferrari R; Sutherland FJ J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023 [TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic and hemodynamic effects of prifuroline. Benharkate M; Plassard G; Legeai J; Worcel M Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836 [TBL] [Abstract][Full Text] [Related]
15. [Ventricular fibrillation and defibrillation; electrophysiological bases and clinical applications]. Davy JM; Pons M; Beck L; Messner-Pellenc P Arch Mal Coeur Vaiss; 1995 Jan; 88 Spec No 1():25-31. PubMed ID: 7786142 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties. Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677 [TBL] [Abstract][Full Text] [Related]
17. Open-thorax guinea pig model for defibrillation. Eynard JN; Malkin RA Lab Anim Sci; 1999 Dec; 49(6):628-33. PubMed ID: 10638498 [TBL] [Abstract][Full Text] [Related]
18. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent. Lynch JJ; Wallace AA; Van der Gaag LH; Baskin EP; Bear CM; Gehret JR; Kothstein T; Stupienski RF; Appleby SD; Sanguinetti MC J Pharmacol Exp Ther; 1993 May; 265(2):720-30. PubMed ID: 8496818 [TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic properties of tetrodotoxin against occlusion-induced arrhythmias in the rat: a novel approach to the study of the antiarrhythmic effects of ventricular sodium channel blockade. Abraham S; Beatch GN; MacLeod BA; Walker MJ J Pharmacol Exp Ther; 1989 Dec; 251(3):1166-73. PubMed ID: 2557414 [TBL] [Abstract][Full Text] [Related]
20. A possible involvement of sodium channel blockade of class-I-type antiarrhythmic agents in postischemic contractile recovery of isolated, perfused hearts. Takeo S; Tanonaka K; Hayashi M; Yamamoto K; Liu JX; Kamiyama T; Yamaguchi N; Miura A; Natsukawa T J Pharmacol Exp Ther; 1995 Jun; 273(3):1403-9. PubMed ID: 7791114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]